PBT: Heading to $3.00 on the Nasdaq on this move. The difference between this and previous moves is that this move looks sustainable. Previous moves were just spikes. This is happening because of the high profile drug failures amongst majors targeting Alzheimer's disease combined with a much more publicity for Prana.
